EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.4.21.89 | (3S)-3-((1R)-1-[(N-decanoyl-L-prolyl-L-threonyl-L-alanyl-L-asparaginyl)amino]ethyl)azetidin-2-one | beta-lactam lipopeptide, 57% inhibition at 0.1 mM | Staphylococcus aureus | |
3.4.21.89 | (3S)-3-((1S)-1-[(N-decanoyl-L-prolyl-L-threonyl-L-alanyl-L-asparaginyl)amino]ethyl)azetidin-2-one | beta-lactam lipopeptide, 47% inhibition at 0.1 mM | Staphylococcus aureus | |
3.4.21.89 | benzyl (2S,5R,6S)-6-[(N-decanoyl-L-prolyl-L-threonyl-L-alanyl-L-asparaginyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]-heptane-2-carboxylate | beta-lactam lipopeptide, 36% inhibition at 0.1 mM | Staphylococcus aureus | |
3.4.21.89 | decanoyl-L-prolyl-L-threonyl-L-alanyl-L-asparaginyl-carboxamide | beta-lactam lipopeptide, 60% inhibition at 100 mM, removal of the beta-lactam moiety results in a loss of activity | Staphylococcus aureus |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.4.21.89 | Staphylococcus aureus | - |
- |
- |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
3.4.21.89 | SpsB | - |
Staphylococcus aureus |